(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
  • Contact Us
  • Donate Today!
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • Articles of Interest
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

FDA Expedites Review of Nubeqa Combination for Metastatic, Hormone-Sensitive Prostate Cancer

by admin_63069 | May 16, 2022 | Articles of Interest

Results from a phase 3 trial showed that the combination of Nubeqa, docetaxel and androgen-deprivation therapy significantly decreased the risk of death for men with a certain type of prostate cancer.

Genetically Adjusted PSA Screening

by admin_63069 | May 12, 2022 | Articles of Interest

Improved screening to reduce over diagnosis and over treatment of prostate cancer

Man Sues After Delayed Diagnosis of Prostate Cancer

by admin_63069 | May 8, 2022 | Articles of Interest

Insurance company contributed to settlement without insured’s consent.

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

by admin_63069 | May 4, 2022 | Articles of Interest

Click to read findings of Weill Cornell Medicine, published March 22 in the Journal of the National Cancer Institute.

Genetically-Adjusted PSA May Be a More Accurate vs PSA Alone as Prostate Cancer Screening Biomarker

by admin_63069 | Apr 30, 2022 | Articles of Interest

Genetic determinants of PSA proved to robustly predict prostate cancer diagnoses and improve the detection of aggressive disease; however, larger and more diverse studies are still required.

What I Wish I’d Known When I Received a Prostate Cancer Diagnosis

by admin_63069 | Apr 26, 2022 | Articles of Interest

Read this perspective shared by a prostate cancer survivor
« Older Entries

What’s New

  • Brachytherapy vs EBRT vs SBRT for Low/Intermediate Risk Disease
  • FDA Expedites Review of Nubeqa Combination for Metastatic, Hormone-Sensitive Prostate Cancer
  • Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer
  • “Shooting for the Moon” Means Reducing Metastatic Prostate Cancer Diagnoses
  • Genetically Adjusted PSA Screening

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org